Take2 Technologies Limited v. Pacific Biosciences of California, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 7 TAKE2 TECHNOLOGIES LIMITED, et Case No. 5:23-cv-04166-EJD al., ORDER GRANTING IN PART Plaintiffs, MOTION TO DISQUALIFY 10 v. Re: ECF No.
PACIFIC BIOSCIENCES OF
CALIFORNIA INC, Defendant. 13 Plaintiffs Take2 Technologies Limited (“Take2”) and the Chinese University of Hong Kong move to disqualify the entire in-house legal department at Defendant Pacific Biosciences of California (“PacBio”). ECF No. 75 (“Mot.”). The Court heard oral arguments on October 26, 2023. Based on the submitted arguments and evidence, the Court GRANTS IN PART Plaintiffs’ motion and ORDERS the parties to meet-and-confer as to the appropriate scope of relief. I. BACKGROUND Prior to August 2022, Ms. Yang Tang was employed as an attorney at Perkins Coie, the law firm that is presently representing Plaintiffs Take2 Technologies Limited (“Take2”) and the Chinese University of Hong Kong. …